ALLBIRDS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS Delivers Third Quarter Results in Line and Above Guidance Ranges Updates Full Year 2025 Revenue Outlook and Reiterates Midpoint of Adjusted EBITDA Guidance SAN FRANCISCO, Calif., November 6, 2025 (GlobeNewswire) – Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that innovates with sustainable materials to make better products in a better way, today reported financial results for the quarter ended September 30, 2025. Net loss for the third quarter ...

Exhibit 99.1 Genpact Reports Third Quarter 2025 Results Net Revenues of $1.291 billion, Up 6.6% (6.0% constant currency) Advanced Technology Solutions Net Revenues of $311 million, Up 20.0% Core Business Services Net Revenues of $980 million, Up 3.0% Data-Tech-AI Net Revenues of $622 million, Up 9.3% (8.9% constant currency) Digital Operations Net Revenues of $669 million, Up 4.3% (3.4% constant currency) Diluted EPS of $0.83, Up 12.2%; Adjusted Diluted EPS of $0.97, Up 14.1% 1 2 2 1 1 3 NEW YORK, November ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) Motorsport Games Inc. (Exact Name of Registrant as Specified in Its Charter) | Delaware | 86-1791356 | | --- | --- | | State or other jurisdiction of | I.R.S. Employer | | incorporation or organization | Identification No. | | 3350 SW 148 Avenue, Suite 207 | | | Miramar, FL | 33027 | | Address of principal executive offices | Zip Code | Registrant's telephone number, including area code: (305) 413-0812 ☒ QUARTERLY R ...

Revenue Performance - First quarter revenue was $2.31 billion, up 21% sequentially and 23% year-over-year, exceeding guidance[4] - The company expects second quarter revenue to be between $2.55 billion and $2.65 billion, with Non-GAAP diluted net income per share projected to be between $3.00 and $3.40[8] - Revenue for the three months ended October 3, 2025, was $2,308 million, a 22.5% increase from $1,883 million for the same period in 2024[20] Income and Profitability - GAAP net income for Q1 2026 was $112 million, a 587% increase from the previous quarter, with diluted net income per share at $0.75[5] - Operating income for Q1 2026 was $176 million, a significant increase of 878% from the previous quarter[5] - Gross profit decreased to $687 million, down 5.4% from $726 million year-over-year[20] - Operating income fell to $176 million, a decline of 39.5% compared to $291 million in the prior year[20] - Net income was $112 million, representing a 46.5% decrease from $211 million in the same quarter last year[20] - Non-GAAP net income increased to $181 million, compared to $263 million in the prior year, reflecting a 31.2% decline[26] Cash Flow - Cash flow provided by operating activities was $488 million, a significant improvement from a cash outflow of $131 million in the same quarter last year[26] - Free cash flow for the quarter was $438 million, compared to a negative $198 million in the same period last year[26] - Free cash flow is defined as cash flows from operating activities less purchases of property, plant, and equipment, net[34] - Adjusted free cash flow includes free cash flow plus activity related to Flash Ventures, net[34] - The company considers free cash flow and adjusted free cash flow as useful indicators for strategic opportunities[34] Expenses and Liabilities - Total current assets decreased to $4.98 billion from $5.09 billion in the previous quarter[18] - Total liabilities decreased to $3.37 billion from $3.77 billion in the previous quarter[18] - Research and development expenses increased to $316 million, up from $283 million year-over-year, indicating a focus on innovation[20] - Total operating expenses rose to $511 million, a 17.5% increase from $435 million in the same quarter last year[20] Business Developments - The company completed its separation from Western Digital Corporation on February 21, 2025, becoming a standalone publicly traded company[10] - Datacenter revenue increased by 26% sequentially, with two hyperscalers in qualification and engagement with five major hyperscale customers[4] - BiCS8 technology accounted for 15% of total bits shipped, expected to dominate bit production by the end of fiscal year 2026[4] - The company incurred $10 million in loss on business divestiture during the quarter, which is not indicative of ongoing operations[31]

Financial Performance - GAAP revenue for Q3 2025 was $118.6 million, a 81.9% increase from $65.2 million in Q3 2024 and a 15.6% increase from $103.0 million in Q2 2025[6] - Total revenue for Q3 2025 reached $118.63 million, a significant increase from $65.15 million in Q3 2024, representing an 82% year-over-year growth[20] - CATV segment revenue was $70.60 million in Q3 2025, compared to $20.95 million in Q3 2024, marking a 236% increase[20] - Datacenter revenue increased to $43.94 million in Q3 2025 from $40.95 million in Q3 2024, reflecting a 5% growth[20] Profitability Metrics - GAAP gross margin was 28.0%, compared to 24.4% in Q3 2024 and 30.3% in Q2 2025; non-GAAP gross margin was 31.0%, up from 25.0% in Q3 2024[6] - Total gross profit for Q3 2025 was $33.26 million, up from $15.92 million in Q3 2024, resulting in a gross margin improvement[20] - The company reported an adjusted EBITDA of $2.01 million for Q3 2025, compared to a loss of $7.69 million in Q3 2024[22] Net Loss - GAAP net loss was $17.9 million, or $0.28 per basic share, compared to a net loss of $17.8 million, or $0.42 per basic share in Q3 2024[6] - The net loss for Q3 2025 was $17.94 million, slightly higher than the net loss of $17.76 million in Q3 2024[20] - Non-GAAP net loss was $5.4 million, or $0.09 per basic share, an improvement from a non-GAAP net loss of $8.8 million, or $0.21 per basic share in Q3 2024[6] - Non-GAAP net loss for Q3 2025 was $5.40 million, compared to a non-GAAP net loss of $8.78 million in Q3 2024, showing improvement[22] Expenses - Operating expenses totaled $51.45 million in Q3 2025, compared to $32.46 million in Q3 2024, indicating a 58% increase[20] - Research and development expenses were $21.27 million in Q3 2025, up from $13.43 million in Q3 2024, a 58% increase[20] Future Outlook - The company expects Q4 2025 revenue to be in the range of $125 million to $140 million, with non-GAAP gross margin between 29% and 31%[10] - The company is nearing final stages of 800G product qualification with several customers, anticipating meaningful shipments in Q4 2025[3] Production and Capacity - Production capacity is expected to reach approximately 100,000 units of 800G transceivers per month by year-end, with 35% of production in the U.S.[3] Assets and Liabilities - Total current assets increased to $575.3 million as of September 30, 2025, compared to $301.3 million at the end of 2024[18] - Total liabilities rose to $419.4 million as of September 30, 2025, up from $317.9 million at the end of 2024[18] Demand and Market Performance - Strong demand in the CATV business led to the highest quarterly CATV revenue in the company's history, driven by orders for 1.8 GHz amplifier products[3]

Revenue Performance - Total revenue for the three months ended September 30, 2025, was $139.6 million, a decrease of 13.6% from $161.6 million in the same period of 2024[181]. - Total revenue for the nine months ended September 30, 2025, was $477.7 million, a decrease of 1.6% from $485.4 million in the same period of 2024[197]. Material Sales - Material sales decreased by 1% to $82.6 million for the three months ended September 30, 2025, compared to $83.4 million in 2024[182]. - Material sales decreased by 5% to $257.4 million for the nine months ended September 30, 2025, compared to $272.2 million for the same period in 2024, with a 4% decrease in unit material volume[198]. Revenue Sources - Revenue from royalty and license fees dropped by 29% to $53.3 million, primarily due to changes in customer mix and a $9.5 million out of period adjustment[183]. - Revenue from contract research services increased by 63% to $17.7 million for the nine months ended September 30, 2025, up from $10.8 million in 2024[202]. - Contract research services revenue increased by 1% to $3.7 million for the three months ended September 30, 2025[188]. Gross Margin - Gross margin decreased by $21.7 million to $104.1 million, with gross margin percentage declining from 78% to 75%[189]. - Gross margin decreased by $9.4 million to $364.9 million for the nine months ended September 30, 2025, with gross margin as a percentage of revenue decreasing to 76% from 77%[203]. Expenses - Research and development expenses increased to $36.3 million, reflecting higher contract research costs[190]. - Research and development expenses decreased to $107.6 million for the nine months ended September 30, 2025, compared to $110.9 million in 2024[204]. - Selling, general and administrative expenses rose to $18.0 million, driven by increased salaries and stock-based compensation[191]. Cash Flow and Investments - Cash provided by operating activities for the nine months ended September 30, 2025, was $179.7 million, down from $219.0 million in 2024[212]. - Cash used in investing activities decreased to $85.0 million for the nine months ended September 30, 2025, compared to $167.1 million in 2024[214]. - Working capital increased to $928.7 million as of September 30, 2025, from $774.4 million as of December 31, 2024[216]. Tax and Market Risk - The effective income tax rate was 19.4% for the nine months ended September 30, 2025, compared to 18.8% in 2024, with income tax expense recorded at $42.4 million[210]. - The company anticipates sufficient cash, cash equivalents, and short-term investments to meet obligations for at least the next twelve months[217]. - The company has no significant market risk exposure other than investments disclosed in "Fair Value Measurements"[224]. Foreign Exchange Risk - Substantially all revenue is derived from outside of North America, primarily in U.S. dollars, minimizing foreign exchange risk from routine customer sales[225]. - The company bears foreign exchange risk from fluctuations in the Korean Won to U.S. dollar exchange rate due to a withholding tax receivable[225]. Accounting Policies and Estimates - The company believes its critical accounting policies include revenue recognition, deferred revenue, inventories, and income taxes[221]. - Actual results may differ significantly from estimates made in the preparation of the Consolidated Financial Statements[220]. - The company has made estimates and judgments that affect reported assets, liabilities, revenues, and expenses[220]. Restructuring and Manufacturing - The company recorded $602,000 in restructuring costs due to the closure of the OVJP Corp facility in California[179]. - The new manufacturing site in Shannon, Ireland is expected to double production capacity upon full operation[180].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-42756 CARLSMED, INC. (Exact Name of Registrant as Specified in its Charter) ( State or other jurisdiction of incorporation or ...

Revenue Performance - Revenue increased by $594,000, or 16%, to $4,231,000 in Q3 2025 compared to $3,637,000 in Q3 2024[74] - Revenue for the nine months ended September 30, 2025, increased by $857,000, or 11%, to $8,786,000 compared to $7,929,000 in the same period of 2024[84] Profitability and Margins - Gross profit was $1,552,000 (37%) in Q3 2025, up from $1,260,000 (35%) in Q3 2024, with a reduction in gross margin attributed to product mix and inventory costs[77] - Gross profit for the nine months ended September 30, 2025, was $2,958,000 (34%), down from $2,938,000 (37%) in 2024, reflecting a decrease in gross margin[86] - Net loss improved to approximately $290,000 in Q3 2025 from $513,000 in Q3 2024, driven by increased revenue and gross margin[83] Expenses - Selling, marketing, and distribution expenses decreased by approximately $49,000 (5%) from $990,000 in Q3 2024 to $941,000 in Q3 2025[78] - General and administrative expenses increased by approximately $139,000 (20%) from $705,000 in Q3 2024 to $844,000 in Q3 2025, primarily due to costs associated with the Arps acquisition[79] - Cost of revenue for the nine months ended September 30, 2025, increased by $837,000, or 17%, to $5,828,000, attributed to trial costs at a new manufacturer[85] Cash Flow and Liquidity - As of September 30, 2025, working capital was $1,626,000, compared to $606,000 at December 31, 2024, primarily due to capital raised through the sale of common stock[99] - During the nine months ended September 30, 2025, the company used $2,173,000 in operations, with a net loss adjusted for non-cash operating expenses of $1,297,000[98] - Liquidity needs depend on the ability to profitably ramp up sales and control variable operating expenses[100] - Operations have been financed through the sale of securities, convertible debt, and short-term debt[101] - Additional funds may be required if sufficient cash flow from operations is not generated[101] Financial Reporting and Compliance - No off-balance sheet arrangements that materially affect financial condition or results of operations[102] - The company is classified as a smaller reporting company, thus not required to disclose market risk[103]

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) Paycom Software, Inc. (Exact name of registrant as specified in its charter) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission File Number: 001-36393 Delaware (State or other ju ...

Financial Performance - Q3 2025 revenue increased 22% year-over-year to $26.1 million, up from $21.3 million in Q3 2024[5] - Q3 2025 gross profit rose 30% year-over-year to $17.5 million, compared to $13.4 million in Q3 2024[5] - GAAP net income for Q3 2025 was $0.8 million, or $0.04 per share, reversing from a net loss of $(9.1) million, or $(0.50) per share in Q3 2024[5] - Non-GAAP net income for Q3 2025 totaled $3.9 million, or $0.20 per diluted share, compared to $2.3 million, or $0.12 per diluted share in Q3 2024[5] - Adjusted EBITDA for Q3 2025 increased to $5.1 million, up from $2.7 million in the same period last year[5] - Net revenue for the three months ended September 30, 2025, was $26,067 million, a 22.5% increase from $21,309 million in the same period of 2024[24] - Gross profit for the nine months ended September 30, 2025, reached $49,495 million, compared to $37,355 million for the same period in 2024, reflecting a 32.4% increase[24] - The company reported a net income of $779 million for the three months ended September 30, 2025, compared to a net loss of $9,124 million in the same period of 2024[24] - Non-GAAP net income for the nine months ended September 30, 2025, was $9,960 million, compared to $6,200 million for the same period in 2024, an increase of 60.3%[29] - Adjusted EBITDA for the nine months ended September 30, 2025, was $12,326 million, compared to $2,882 million for the same period in 2024, indicating a substantial increase[30] Guidance and Projections - Full year 2025 revenue guidance increased to a range of $105 million to $109 million, with adjusted EBITDA guidance of $16 million to $19 million[1][7] - 2026 revenue guidance introduced at a range of $118 million to $124 million, with adjusted EBITDA expected between $19 million and $22 million[1][7] Cash and Operating Activities - Cash and cash equivalents as of September 30, 2025, totaled $19.5 million, up from $13.4 million as of December 31, 2024[5] - Cash provided by operating activities for the nine months ended September 30, 2025, was $11,627 million, significantly higher than $4,691 million in the same period of 2024[26] - The company reported a net increase in cash and cash equivalents of $6,139 million for the nine months ended September 30, 2025, compared to $2,274 million in the same period of 2024[26] Operating Expenses - Operating expenses decreased to $15,466 million for the three months ended September 30, 2025, down from $22,009 million in the same period of 2024, a reduction of 29.8%[24] - Total operating expenses for the nine months ended September 30, 2025, were $46,371 million, down from $54,695 million in the same period of 2024, a decrease of 15.2%[24] Revenue Metrics - Net revenue retention for the twelve months ended September 30, 2025, was 120%, down from 127% in the previous year[6] - Average revenue per top 20 pharmaceutical manufacturer increased to $3,073, compared to $2,874 in the prior year[6]